Report Detail
Global Human Microbiome Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q4 2018 Update)
- RnM3122445 |
- 14 March, 2019 |
- Global |
- 132 Pages |
- 360iResearch |
- Other
The global human microbiome market is expected to grow from USD 488.99 million 2017 to USD 1,985.68 million by the end of 2024 at a Compound Annual Growth Rate (CAGR) of 22.16%.
“Increased focus on human microbiome therapy
is one of the factors largely attributing to the growth of human microbiome market globally”
The factors attributing to the growth of the market are increased focus on human microbiome therapy, and human microbiome for drug development, early disease detection, and diagnosis. However, some factors such as and limited expertise and lack of comprehensive research may hinder the market growth. The global human microbiome market is expected to showcase the opportunities such as increasing collaborations and research investments to create growth opportunities, and development of human microbiome therapeutic products. In the near future, the market may face the possible challenges in the growth due to and causal links between microbiota dysbiosis and disease. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the global human microbiome market market.“Acute Diarrhea: The highest growing disease for the global human microbiome market”
On the basis of disease, the global human microbiome market is studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity. Among all these disease, the Acute Diarrhea is projected to hold the largest market share while the Cancer has the potential to grow the market with the highest CAGR in the forecast period.“Prebiotics: The highest growing product for the global human microbiome market”
On the basis of product, the global human microbiome market is studied across Diagnostic Devices, Drugs, Foods, Medical Foods, Prebiotics, and Probiotics. Among all these product, the Prebiotics is projected to hold the largest market share while the Drugs has the potential to grow the market with the highest CAGR in the forecast period.“Metagenomic Sequencing: The highest growing technology for the global human microbiome market”
On the basis of technology, the global human microbiome market is studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology. Among all these technology, the Metagenomic Sequencing is projected to hold the largest market share while the 16s rRNA Sequencing has the potential to grow the market with the highest CAGR in the forecast period.“Gastrointestinal Disorders: The highest growing theuraptic area for the global human microbiome market”
On the basis of theuraptic area, the global human microbiome market is studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women’s Health. Among all these theuraptic area, the Gastrointestinal Disorders is projected to hold the largest market share while the Skin Disorders has the potential to grow the market with the highest CAGR in the forecast period.“Therapeutics: The highest growing application for the global human microbiome market”
On the basis of application, the global human microbiome market is studied across Diagnostics and Therapeutics. Among all these application, the Therapeutics has captured the maximum market share while the Diagnostics has the opportunity to emerge with the highest CAGR.“Americas: The highest growing geography for the global human microbiome market”
On the basis of geography, the global human microbiome market is studied across Americas, (United States, Brazil, Canada, Mexico, and Argentina) Europe, Middle East & Africa, (United Kingdom, Germany, France, Saudi Arabia, United Arab Emirates, Italy, and Russia) and Asia-Pacific (China, Japan, India, and Australia). Among all these geography, the Asia-Pacific is showing the maximum growth in the near future with the highest CAGR while the Americas is dominating the market with highest market size.
“DuPont: The potential growing player for the global human microbiome market”
The key players profiled in the global human microbiome market are DuPont, E.I. Du Pont De Nemours and Company, Enterome Bioscience, Merck & Co., Inc., Metabiomics Corporation, Microbiome Therapeutics, LLC, Osel, Inc., Second Genome, Inc., Seres Therapeutics, Synthetic Biologics Inc., Vedanta Biosciences, Inc., Vithera Pharmaceuticals, and Yakult Honsha Co., Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the global human microbiome market.
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the global human microbiome market.
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the global human microbiome market.
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the global human microbiome market.
5. Competitive Assessment & Intelligence: Provides exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global human microbiome market.
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Stakeholders
2. Research & Forecasting
- 2.1. Research Methodology
- 2.1.1. Research Instruments
- 2.1.1.1. Secondary Instrument
- 2.1.1.2. Primary Instrument
- 2.1.2. Research Approaches
- 2.1.2.1. Bottom-up Approach
- 2.1.2.2. Top-down Approach
- 2.1.3. Research Reliability & Validity
- 2.1.4. Research Assumptions
- 2.1.5. Vendor Inclusion Criteria
- 2.1.1. Research Instruments
- 2.2. Forecasting Methodology
- 2.2.1. Methodology for Market Estimation & Forecasting
- 2.2.2. Significance and Importance of the Market Estimation & Forecasting
3. Executive Summary
4. Premium Insight
- 4.1. Market Connectivity
- 4.2. Market Data Feed
- 4.3. Market Vendor Ranking Analysis
- 4.4. Market Dynamics
- 4.4.1. Drivers
- 4.4.1.1. Increased focus on human microbiome therapy
- 4.4.1.2. Human microbiome for drug development, early disease detection, and diagnosis
- 4.4.2. Restraints
- 4.4.2.1. Limited expertise and lack of comprehensive research
- 4.4.3. Opportunities
- 4.4.3.1. Increasing collaborations and research investments to create growth opportunities
- 4.4.3.2. Development of human microbiome therapeutic products
- 4.4.4. Challenges
- 4.4.4.1. Causal links between microbiota dysbiosis and disease
- 4.4.1. Drivers
- 4.5. Porter’s Five Forces Analysis
- 4.5.1. Threat of New Entrants
- 4.5.2. Threat of Substitutes
- 4.5.3. Bargaining Power of Customers
- 4.5.4. Bargaining Power of Suppliers
- 4.5.5. Industry Rivalry
- 4.6. Regulatory Framework
- 4.7. Patent & Funding
- 4.8. Impact of Human Microbiome Therapeutics on Current Treatment Options
5. Global Human Microbiome Market, by Disease
- 5.1. Introduction
- 5.2. Acute Diarrhea
- 5.3. Autoimmune Disorders
- 5.4. Cancer
- 5.5. Diabetes
- 5.6. Mental Disorders
- 5.7. Obesity
6. Global Human Microbiome Market, by Product
- 6.1. Introduction
- 6.2. Diagnostic Devices
- 6.3. Drugs
- 6.4. Foods
- 6.5. Medical Foods
- 6.6. Prebiotics
- 6.7. Probiotics
7. Global Human Microbiome Market, by Technology
- 7.1. Introduction
- 7.2. 16s rRNA Sequencing
- 7.3. Cell Culture Technology
- 7.4. Computational Tools
- 7.5. High-Throughput Technology
- 7.6. Metagenomic Sequencing
- 7.7. Omics Technology
8. Global Human Microbiome Market, by Theuraptic Area
- 8.1. Introduction
- 8.2. Gastrointestinal Disorders
- 8.3. Metabolic Disorders
- 8.4. Skin Disorders
- 8.5. Women’s Health
9. Global Human Microbiome Market, by Application
- 9.1. Introduction
- 9.2. Diagnostics
- 9.3. Therapeutics
10. Global Human Microbiome Market, by Geography
- 10.1. Introduction
- 10.2. Americas Human Microbiome Market
- 10.2.1. Americas Human Microbiome Market, by Country
- 10.2.1.1. United States
- 10.2.1.2. Brazil
- 10.2.1.3. Canada
- 10.2.1.4. Mexico
- 10.2.1.5. Argentina
- 10.2.2. Americas Human Microbiome Market, by Disease
- 10.2.3. Americas Human Microbiome Market, by Product
- 10.2.4. Americas Human Microbiome Market, by Technology
- 10.2.5. Americas Human Microbiome Market, by Theuraptic Area
- 10.2.6. Americas Human Microbiome Market, by Application
- 10.2.1. Americas Human Microbiome Market, by Country
- 10.3. Europe, Middle East & Africa Human Microbiome Market
- 10.3.1. Europe, Middle East & Africa Human Microbiome Market, by Country
- 10.3.1.1. United Kingdom
- 10.3.1.2. Germany
- 10.3.1.3. France
- 10.3.1.4. Saudi Arabia
- 10.3.1.5. United Arab Emirates
- 10.3.1.6. Italy
- 10.3.1.7. Russia
- 10.3.2. Europe, Middle East & Africa Human Microbiome Market, by Disease
- 10.3.3. Europe, Middle East & Africa Human Microbiome Market, by Product
- 10.3.4. Europe, Middle East & Africa Human Microbiome Market, by Technology
- 10.3.5. Europe, Middle East & Africa Human Microbiome Market, by Theuraptic Area
- 10.3.6. Europe, Middle East & Africa Human Microbiome Market, by Application
- 10.3.1. Europe, Middle East & Africa Human Microbiome Market, by Country
- 10.4. Asia-Pacific Human Microbiome Market
- 10.4.1. Asia-Pacific Human Microbiome Market, by Country
- 10.4.1.1. China
- 10.4.1.2. Japan
- 10.4.1.3. India
- 10.4.1.4. Australia
- 10.4.2. Asia-Pacific Human Microbiome Market, by Disease
- 10.4.3. Asia-Pacific Human Microbiome Market, by Product
- 10.4.4. Asia-Pacific Human Microbiome Market, by Technology
- 10.4.5. Asia-Pacific Human Microbiome Market, by Theuraptic Area
- 10.4.6. Asia-Pacific Human Microbiome Market, by Application
- 10.4.1. Asia-Pacific Human Microbiome Market, by Country
11. Competitive Strategic Window
- 11.1. Introduction
- 11.1.1. Leverage Zone
- 11.1.2. Vantage Zone
- 11.1.3. Speculative Zone
- 11.1.4. Bottleneck Zone
12. FPNV Positioning Matrix
- 12.1. Introduction
- 12.2. Scores
- 12.2.1. Forefront
- 12.2.2. Pathfinders
- 12.2.3. Niche
- 12.2.4. Vital
- 12.3. Business Strategy
- 12.4. Product Satisfaction
13. Competitive News Feed Analysis
14. Company Usability Profiles
- 14.1. DuPont
- 14.2. E.I. Du Pont De Nemours and Company
- 14.3. Enterome Bioscience
- 14.4. Merck & Co., Inc.
- 14.5. Metabiomics Corporation
- 14.6. Microbiome Therapeutics, LLC
- 14.7. Osel, Inc.
- 14.8. Second Genome, Inc.
- 14.9. Seres Therapeutics
- 14.10. Synthetic Biologics Inc.
- 14.11. Vedanta Biosciences, Inc.
- 14.12. Vithera Pharmaceuticals
- 14.13. Yakult Honsha Co., Ltd.
15. Appendix
- 15.1. Top Reports
- 15.2. Author Details
LIST OF TABLES (56 TABLES)
TABLE 1. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 2. GLOBAL HUMAN MICROBIOME MARKET RANKING, BY VENDORS, 2017
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2016 - 2024 (USD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MEDICAL FOODS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2016 - 2024 (USD MILLION)
TABLE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2016 - 2024 (USD MILLION)
TABLE 33. AMERICAS HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 34. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2016 - 2024 (USD MILLION)
TABLE 35. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 36. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 37. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2016 - 2024 (USD MILLION)
TABLE 38. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2016 - 2024 (USD MILLION)
TABLE 41. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2016 - 2024 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 45. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
TABLE 46. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2016 - 2024 (USD MILLION)
TABLE 47. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2016 - 2024 (USD MILLION)
TABLE 48. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2016 - 2024 (USD MILLION)
TABLE 49. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2016 - 2024 (USD MILLION)
TABLE 50. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2016 - 2024 (USD MILLION)
TABLE 51. 360IRESEARCH SCORES FOR FOREFRONT IN HUMAN MICROBIOME MARKET
TABLE 52. 360IRESEARCH SCORES FOR PATHFINDERS IN HUMAN MICROBIOME MARKET
TABLE 53. 360IRESEARCH SCORES FOR NICHE IN HUMAN MICROBIOME MARKET
TABLE 54. 360IRESEARCH SCORES FOR VITAL IN HUMAN MICROBIOME MARKET
TABLE 55. 360IRESEARCH FPNV POSITIONING MATRIX BUSINESS STRATEGY FOR HUMAN MICROBIOME MARKET
TABLE 56. 360IRESEARCH FPNV POSITIONING MATRIX PRODUCT SATISFACTION FOR HUMAN MICROBIOME MARKET
LIST OF FIGURES (48 TABLES)
FIGURE 1. GLOBAL HUMAN MICROBIOME MARKET: YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL HUMAN MICROBIOME MARKET: KEY RESEARCH METHODOLOGY
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET: KEY RESEARCH INSTRUMENTS
FIGURE 4. GLOBAL HUMAN MICROBIOME MARKET: KEY SECONDARY INSTRUMENT SOURCES
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET: KEY POTENTIAL RESPONDENTS
FIGURE 6. GLOBAL HUMAN MICROBIOME MARKET: KEY BREAKDOWN OF PRIMARY INSTRUMENT
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET: KEY RESEARCH APPROACHES
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET: KEY DATA TRIANGULATION
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET: KEY RESEARCH ASSUMPTIONS
FIGURE 10. HUMAN MICROBIOME MARKET: KEY MARKET CONNECTIVITY
FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, 2016 - 2024 (USD MILLION)
FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2017 VS 2024 (USD MILLION)
FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2017 VS 2024 (USD MILLION)
FIGURE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MEDICAL FOODS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PROBIOTICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2017 VS 2024 (USD MILLION)
FIGURE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THEURAPTIC AREA, 2017 VS 2024 (USD MILLION)
FIGURE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2017 VS 2024 (USD MILLION)
FIGURE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY GEOGRAPHY, 2017 VS 2024 (USD MILLION)
FIGURE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GEOGRAPHY, 2017 (USD MILLION)
FIGURE 42. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY DISEASE, 2024
FIGURE 43. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY PRODUCT, 2024
FIGURE 44. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY TECHNOLOGY, 2024
FIGURE 45. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY THEURAPTIC AREA, 2024
FIGURE 46. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY APPLICATION, 2024
FIGURE 47. 360IRESEARCH COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET, BY GEOGRAPHY, 2024
FIGURE 48. 360IRESEARCH FPNV POSITIONING MATRIX FOR HUMAN MICROBIOME MARKET
Summary:
Get latest Market Research Reports on Human Microbiome . Industry analysis & Market Report on Human Microbiome is a syndicated market report, published as Global Human Microbiome Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q4 2018 Update). It is complete Research Study and Industry Analysis of Human Microbiome market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
